General MedicationsORALStandard

GRISEOFULVIN, ULTRAMICROSIZE

Standard Dose

125MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview GRISEOFULVIN, ULTRAMICROSIZE is listed in Drugs@FDA under application 204371 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GRISEOFULVIN, ULTRAMICROSIZE Form and strength TABLET;ORAL - 125MG Sponsor MOUNTAIN Submission history Latest submission status date: 2025-03-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRISEOFULVIN, ULTRAMICROSIZE is listed in Drugs@FDA under application 204371 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GRISEOFULVIN, ULTRAMICROSIZE Form and strength TABLET;ORAL - 125MG Sponsor MOUNTAIN Submission history Latest submission status date: 2025-03-20 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.